The cofilin pathway in breast cancer invasion and metastasis

Research output: Contribution to journalArticle

331 Citations (Scopus)

Abstract

Recent evidence indicates that metastatic capacity is an inherent feature of breast tumours and not a rare, late acquired event. This has led to new models of metastasis. The interpretation of expression-profiling data in the context of these new models has identified the cofilin pathway as a major determinant of metastasis. Recent studies indicate that the overall activity of the cofilin pathway, and not that of any single gene within the pathway, determines the invasive and metastatic phenotype of tumour cells. These results predict that inhibitors directed at the output of the cofilin pathway will have therapeutic benefit in combating metastasis.

Original languageEnglish (US)
Pages (from-to)429-440
Number of pages12
JournalNature Reviews Cancer
Volume7
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Actin Depolymerizing Factors
Breast Neoplasms
Neoplasm Metastasis
Phenotype
Genes
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

The cofilin pathway in breast cancer invasion and metastasis. / Wang, Weigang; Eddy, Robert J.; Condeelis, John S.

In: Nature Reviews Cancer, Vol. 7, No. 6, 06.2007, p. 429-440.

Research output: Contribution to journalArticle

@article{0415ac80d3e74fe18e1328112965b640,
title = "The cofilin pathway in breast cancer invasion and metastasis",
abstract = "Recent evidence indicates that metastatic capacity is an inherent feature of breast tumours and not a rare, late acquired event. This has led to new models of metastasis. The interpretation of expression-profiling data in the context of these new models has identified the cofilin pathway as a major determinant of metastasis. Recent studies indicate that the overall activity of the cofilin pathway, and not that of any single gene within the pathway, determines the invasive and metastatic phenotype of tumour cells. These results predict that inhibitors directed at the output of the cofilin pathway will have therapeutic benefit in combating metastasis.",
author = "Weigang Wang and Eddy, {Robert J.} and Condeelis, {John S.}",
year = "2007",
month = "6",
doi = "10.1038/nrc2148",
language = "English (US)",
volume = "7",
pages = "429--440",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - The cofilin pathway in breast cancer invasion and metastasis

AU - Wang, Weigang

AU - Eddy, Robert J.

AU - Condeelis, John S.

PY - 2007/6

Y1 - 2007/6

N2 - Recent evidence indicates that metastatic capacity is an inherent feature of breast tumours and not a rare, late acquired event. This has led to new models of metastasis. The interpretation of expression-profiling data in the context of these new models has identified the cofilin pathway as a major determinant of metastasis. Recent studies indicate that the overall activity of the cofilin pathway, and not that of any single gene within the pathway, determines the invasive and metastatic phenotype of tumour cells. These results predict that inhibitors directed at the output of the cofilin pathway will have therapeutic benefit in combating metastasis.

AB - Recent evidence indicates that metastatic capacity is an inherent feature of breast tumours and not a rare, late acquired event. This has led to new models of metastasis. The interpretation of expression-profiling data in the context of these new models has identified the cofilin pathway as a major determinant of metastasis. Recent studies indicate that the overall activity of the cofilin pathway, and not that of any single gene within the pathway, determines the invasive and metastatic phenotype of tumour cells. These results predict that inhibitors directed at the output of the cofilin pathway will have therapeutic benefit in combating metastasis.

UR - http://www.scopus.com/inward/record.url?scp=34249281332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249281332&partnerID=8YFLogxK

U2 - 10.1038/nrc2148

DO - 10.1038/nrc2148

M3 - Article

C2 - 17522712

AN - SCOPUS:34249281332

VL - 7

SP - 429

EP - 440

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 6

ER -